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Abstract 28 
In the present study we aimed to investigate the incidence and predictors of spirometry based 29 
airway obstruction in a representative population-based sample.  30 
Altogether 3863 subjects, 1651 males and 2212 females aged > 30 years had normal spirometry in 31 
year 2000. 53% of them were never and 23% current smokers.  A re-spirometry was performed 11 32 
years later. Several characteristics, such as level of education, use of alcohol, physical activity, diet 33 
using AHEI index, BMI, circumwaist, sensitive CRP and cotinine of the laboratory values and co-34 
morbidities including asthma, allergic rhinitis, sleep apnoea and chronic bronchitis, as potential risk 35 
factors for airway obstruction were evaluated.  36 
Using FEV1/FVC below the lower limit of normal, we observed 124 new cases of airway 37 
obstruction showing a cumulative 11-year incidence of 3.2% and corresponding to an incidence rate 38 
of 5.6/1000 PY. The incidence rate was higher in men than in women (6.3/1000PY vs. 5.0/1000PY, 39 
respectively). The strongest risk factors were current smoking (OR 2.5) and previously diagnosed 40 
asthma (OR 2.1). Sensitive CRP associated with the increased risk and high AHEI index with the 41 
decreased risk of airway obstruction.  42 
Using the similar study approach our findings on the incidence of airway obstruction are in line 43 
with the previously published figures in Europe. We were able to confirm the recent findings on the 44 
protective effect of healthy diet.   45 
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Introduction 49 
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity, disability 50 
and death worldwide [1, 2]. Based on a global estimate in 2010 the prevalence of COPD in adults 51 
over 30 years of age was 11.4% being more prevalent among males (14.3%) than females (7.6%) 52 
[3]. 53 
In studies on COPD incidence, two main approaches have been used. First, diagnosis based studies 54 
have attempted to define COPD based on clinical outcomes such as outpatient contacts, hospital 55 
visits for exacerbations, or self-reported physician diagnosed COPD. These studies have reported 56 
incidence rates around 2.6–2.9 cases / 1.000 patient years (PY) with higher incidence rates found in 57 
males and among older age categories [4,5]. The second approach is based on by showing 58 
irreversible airway obstruction in spirometry. Furthermore, the definition of airway obstruction 59 
varies [6-12]. Many epidemiological studies have used the Global Initiative on Obstructive Lung 60 
Disease (GOLD) definition of a fixed ratio of forced expiratory volume in one second (FEV1) to 61 
forced vital capacity (FVC) below 0.70. Fixed ratio has the benefit of easy comparability between 62 
populations, but is known to give false positives in subjects over 50 years of age. One example of 63 
this is the Rotterdam study, the incidence was almost 50% lower when population based reference 64 
values were used instead of the fixed ratio (5.5/1.000 PY vs. 8.9/1.000 PY), respectively [7].There 65 
is a large number of population based epidemiological studies that have evaluated the incidence of 66 
airway obstruction based on fixed ratio with widely varying incidence rates, 2.8–16.0 /1.000 PY [7-67 
12]. Population age distribution, smoking habits and sampling differences can partially explain 68 
these widely varying incidence estimates.  69 
Smoking is the main causative factor for COPD [2], but also other -causative and predisposing -70 
factors have been recognised. Many of them are linked to low socioeconomic status [13], 71 
occupational exposures [14] and old age [15]. Of studied biomarkers, sensitive C-reactive protein 72 
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shows the most constant association to low lung function and COPD [16]. Recently the diet has 73 
become of great interest, especially the association between low vitamin D levels and declined lung 74 
function [17], even though no causality to the incidence of COPD could be observed [18]. Also an 75 
association has been observed between high consumption of processed meat and lower lung 76 
function [19], whereas high fruit and vegetable consumption lowered the risk of COPD among 77 
current and ex-smokers [20]. Lately, high Alternate healthy eating index (AHEI 2010) has been 78 
associated with a lower risk of COPD [21].  79 
The primary objective of this study was to investigate the incidence of airway obstruction in a 80 
population with high standard of living and smoking steadily decreasing [22, 23]. Spirometry based 81 
incidence on airway obstruction have never been published in Finland. The secondary objective was 82 
to find out associative factors of development of airway obstruction. 83 
 84 
Methods 85 
A sample of 9922 subjects aged 18 years or over was drawn from the population register (two-stage 86 
stratified, random sample) and invited to a comprehensive health survey (Health 2000 survey) in 87 
2000-2001 [24]. Of these subjects, 8028 (3637 males and 4391 females) were aged 30 years or 88 
over, and of whom altogether 6354 (79%) subjects completed the health examination, donated 89 
blood samples, and performed spirometry.  90 
All study subjects of Health 2000 survey who lived in Finland were invited to participate Health 91 
2011 survey (n=8135 subjects), and 58.2% (4736/8135) of them completed the health examination. 92 
The study population in the present study comprised of those 3863 subjects who were aged 30 years 93 
or over in Health 2000, participated and performed spirometry in both Health 2000 and Health 2011 94 
surveys and had normal spirometry in Health 2000 survey. 95 
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Our aim was to analyse how baseline data collected in Health 2000 survey predicted airway 96 
obstruction in follow-up until Health 2011 survey. In Health 2000 survey information on age and 97 
gender (female/male) were obtained from population register. Height, weight and circumwaist were 98 
measured. Body mass index (BMI) (weight (kg)/height² (m²)) was determined. The use of alcohol 99 
during previous 12 months was determined and categorised as: no, seldom (use of alcohol twice in a 100 
month or less) and often (use of alcohol once in a week or more often).  101 
Smoking history was obtained through a standard interview and classified into three categories: 102 
never-smokers (those who had smoked daily less than 1 year during their life-time and quit smoking 103 
at least one month earlier), former smokers (those who had smoked daily over a year and quit 104 
smoking at least one month earlier) and current smokers (those who had smoked daily over a year 105 
and at least one cigarette, cigar or pipe for less than a month ago at any time preceding the survey). 106 
Educational level was categorised into three groups (basic, secondary, or higher). Leisure physical 107 
activity was classified into three groups: low (little physical exercise), moderate (exercise in 108 
connection with some hobbies or irregularly), or high (regular exercise). 109 
Subjects were considered asthmatic if they reported that they had been diagnosed with asthma by a 110 
physician, that they were currently in a physician’s control and received medication for asthma. The 111 
history, symptoms and possible findings of allergic rhinitis, chronic bronchitis, and sleep apnoea 112 
were inquired about in the basic questionnaire and categorised as having these or not.  113 
Participants’ habitual dietary intake over preceding 12 months was collected with a validated 128-114 
item semi quantitative food frequency questionnaire (FFQ) [25, 26]. Adherence to the healthy diet 115 
was measured using the Alternate Healthy Eating Index (AHEI) developed by McCullough et al. 116 
(2002) [27]. The AHEI in our data included the intake of seven components (vegetables; fresh fruits 117 
and berries; nuts and legumes; rye; the ratio of white to red meat; the ratio of polyunsaturated to 118 
saturated fat; trans fat), which were divided into sex-specific quintiles. The first six components 119 
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received scores in an ascending order, so that one point was assigned for intakes in the lowest 120 
quintile and five points for intakes in the highest quintile. The trans fats component received scores 121 
in the descending order, with the lowest quintile gaining a value of five points and the highest 122 
quintile a value of one point.  The total score ranged from 7 (worst) to 35 (best), with higher score 123 
values representing greater adherence to a healthy diet. Total energy in take was measured in 124 
kilocalories (kcal) according to the FFQ. 125 
Serum samples used to characterise the participants were collected and frozen at -20 °C and stored 126 
at -70 °C. Cotinine concentrations were determined by a modified method of the Nicotine 127 
Metabolite RIA kit (Diagnostic Products Corporation, LA, USA). For cotinine a cut-off point of 128 
100 µg/L or over was used to separate smokers from non-smokers. The level of sensitive C reactive 129 
protein (sCRP) was determined using a chemiluminescent immunometric assay (Immulite, 130 
Diagnostic Products Corporation, Los Angeles, CA, USA). 131 
In Health 2000, Vitalograph bellow spirometers (Vitalograph Ltd., Buckingham, England) were 132 
used, while in Health 2011 the Medikro® SpiroStar flow-volume spirometer and Medikro ® 133 
Spiro2000 software, was used. To ensure comparability between the measurements a validation 134 
study was performed, which showed no significant difference between the two devices [24]. The 135 
spirometers were calibrated with a one-litre calibration pump, and the equipment was checked every 136 
morning before the measurements. The measurements were made by specially trained laboratory 137 
technicians following standard guidelines and instructions. The technicians demonstrated the test 138 
procedure to all subjects individually. When the subject had learned the technique and rehearsed it 139 
once or twice, the aim was to produce at least two as consistent curves as possible. For forced 140 
expiratory volume in one second (FEV1) and forced vital capacity (FVC) the technician instructed 141 
the subjects to fill their lungs with air and then to exhale as forcefully and completely as possible, 142 
urging them towards the end of the test.  Failed efforts and those with questionable performance due 143 
to fatigue, or otherwise poor co-operation were excluded from the analysis. The quotient FEV1/FVC 144 
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was calculated using the highest readings of FEV1 and FVC from technically acceptable efforts 145 
recorded in BTPS (body temperature and pressure, saturated with water vapour) values. FEV1/FVC 146 
below the lower limit of normal (< LLN) was considered to indicate airway obstruction. 147 
Bronchodilation was not performed for all subjects. The individual results were computed on the 148 
basis of the GLI reference values [6] for corresponding age, sex and height were used. Development 149 
of a new airway obstruction was analysed from the spirometry performed in Health 2011. 150 
Health 2000 study was approved by the Ethics Committee for Epidemiology and Public Health in 151 
the Hospital District of Helsinki and Uusimaa and Health 2011 in the Coordinating Ethics 152 
Committee of the Hospital District of Helsinki and Uusimaa. All participants gave their written 153 
informed consent.  154 
The sampling design was accounted for in all analyses using the survey package [28, 29] of the R 155 
statistical software package [R Core Team (2017). R: A language and environment for statistical 156 
computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-157 
project.org/]. The effects of oversampling of the 80-year old and older in 2000, and nonresponse in 158 
the full sample were accounted for using the inverse probability weighting [30]. 159 
Regression analyses were based on generalised linear models. In addition to the simple regression 160 
models containing the risk factors one at a time, in which only age and sex were adjusted for (model 161 
1), we adjusted also for age, sex and level of education (model 2), for age, sex and smoking (model 162 
3), for age, sex, level of education and smoking (model 4) and also a fully adjusted multiple 163 
regression model containing all aforementioned risk factors (model 5) was analysed. Crude 164 
incidence rates and their 95% confidence intervals were calculated per 1000 person years. 165 
 166 
Results 167 
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There were altogether 3863 subjects, 1651 (42.7%) males and 2212 (57.3%) females, with normal 168 
spirometry during the first survey and a re-performed spirometry 11 years later. Baseline 169 
characteristics in the study population including demographics, physical examinations, tested 170 
laboratory values and patient reported outcomes at baseline are described in Table 1. The 171 
prevalence of nonresponders who participated in Health 2000 but not in Health 2011 was biggest in 172 
subjects aged 65–100 in Health 2000. 173 
New cases of airway obstruction occurred in 124 subjects, with a cumulative 11-year incidence of 174 
3.2% corresponding to an incidence rate of 5.6/1000 person-years (PY) (95% CI 3.8–5.6) (Table 2). 175 
The incidence rate of males was higher (6.3/1000PY, 95% CI 4.9–8.2) and that of females 176 
(5.0/1000PY, 95% CI 3.9–6.6). The highest incidence rate, 9.9/1000PY (95% CI 4.8–16.7), was in 177 
the age group of 65–100 years. 178 
The development of airway obstruction associated in fully adjusted multiple regression model with 179 
current smoking, previously diagnosed asthma, increasing sCRP and decreasing AHEI index, and of 180 
these current smoking and previously diagnosed asthma were the strongest risks for airway 181 
obstruction (Table 1). In basic model with age and sex adjustment development of airway 182 
obstruction associated also with low physical activity, chronic bronchitis, decreasing BMI and waist 183 
circumference, and additionally, decreasing AHEI index meaning healthy diet protected from 184 
airway obstruction whereas the total energy intake did not have an effect. Cotinine had no 185 
association with airway obstruction in fully adjusted model (not reported). Cotinine and self-186 
reported smoking are indicators of same phenomenon taking power in analysis from each other, 187 
though cotinine ≥ 100 μg/mL had an association with airway obstruction in other models (Table 1).  188 
 189 
Discussion 190 
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In this study the incidence of airway obstruction based on spirometry (FEV1/FVC below the lower 191 
limit of normal) was evaluated in a population based cohort (age > 30 years of age) with a follow-192 
up of 11 years. The overall incidence rate was 5.6/1000 PY, 6.3/1000 PY for males and 5.0/1000 193 
PY for females. The main determinants for the development of airway obstruction were current 194 
smoking, previously diagnosed asthma, increased sCRP and low AHEI index. 195 
In previous studies the incidence rates of COPD have varied from 2.6–16.0 per 1000 PY [4,5,7-12]. 196 
The wide variation can be at least partially explained by differences in study approaches. When the 197 
incidence rates are based on retrospective health registries, such as given diagnoses, hospital 198 
admission data or use of medication, the data is highly dependent on the probability of a patient 199 
seeking for medical help, the diagnostic practices of different kind of health-care facilities as well as 200 
the coverage of register data. Studies evaluating self-reported physician-diagnosed COPD, 201 
symptoms or medications indicative of COPD are dependent on the participants’ understanding on 202 
his or her health.  203 
When the estimates are based on spirometry data, it is possible to find also the undiagnosed cases. 204 
Spirometry based incidence studies are also more comparable to each other, even though the 205 
definition of the cut-off value for airway obstruction can vary. Fixed FEV1/FVC –ratio used 206 
frequently in many epidemiological studies is naturally lower in tall subjects and reduces with 207 
normal ageing. In the present study we used the lower limit of normal (LLN) which is individually 208 
predicted to determine airway obstruction in comparison to age and body size match healthy, non-209 
smoking population. These estimates do not cause age or size related bias in the results. In the 210 
Rotterdam Study, the pre-bronchodilator FEV1/FVC < 0.70 or in the absence of spirometry, COPD 211 
diagnosis verified from medical records, resulted in an incidence rate of 8.9/1000 PY. Based on 212 
spirometry data alone the incidence rate of 11.7/1000 PY was observed with fixed ratio and much 213 
lower incidence of 5.2/1000PY with LLN criteria [7]. This was in line with our results. In the 214 
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Netherlands, however smoking was more prevalent. Only 35% of subjects were non-smokers, 215 
compared to 53% in the Finnish population [7]. 216 
Current smoking and previous diagnosis of asthma associated independently to incident airway 217 
obstruction, both well recognised risk factors of COPD [2]. Smoking had decreased in the Health 218 
2000 survey significantly during the follow-up time of 11 years, among the men in all age cohorts 219 
and among the women in age cohorts of 30–54 years [23]. The earlier finding of an association 220 
between sCRP and COPD was also confirmed in this study [16]. 221 
The protective effect of a healthy diet has been under recent research interest. In this study, an 222 
inverse association between AHEI index and incident, spirometry based airway obstruction was 223 
observed. The association reminded significant in all models performed which means healthy diet 224 
protected from airway obstruction regardless of energy intake. High AHEI index reflects the 225 
protective effect of high intakes of whole grains, polyunsaturated fatty acids, nuts and long chain 226 
omega-3 fats and low intakes of red/processed meats, refined grains and sugar sweetened drinks. 227 
Earlier studies have reported that high fruit and vegetable consumption [20] and more-frequent fish 228 
intake [26, 31] can protect from the disease. AHEI score has been studied in clinical COPD only 229 
once and an inverse association between higher AHEI score and the incidence of COPD was 230 
observed [21].  In this large prospective study diagnosis of COPD was based on self-reported 231 
questionnaire. As a validation study, a random sample of medical records of the participants were 232 
assessed. In 71% of the COPD cases spirometry was available confirming the self-reported COPD 233 
[21].  234 
In addition to COPD, chronic bronchitis is a symptom of multiple other conditions [32]. Therefore, 235 
our result about chronic bronchitis having association with new airway obstruction only in age and 236 
sex adjusted model is rational. In BOLD study 129 (11%) subjects had both chronic bronchitis and 237 
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COPD [32], while we found that 9 (7.6%) of those with new obstruction reported symptoms of 238 
chronic bronchitis; these results being comparable. 239 
A limitation in our study is that bronchodilation test was not performed for all, and therefore, we 240 
could not separate reversible and non-reversible airway obstruction. However, our study population 241 
was aged 30 and over at baseline and only 14 subjects (11.2%, Table 1) with new airway 242 
obstruction reported to have asthma in Health 2011, and therefore apparently most of these with 243 
new airway obstruction are COPD [33]. Values of the risk factors, such as smoking status, sCRP 244 
and AHEI index, might have changed during follow-up and have some effect on our results, but as 245 
our objective was to assess the potential predictors of obstruction incidence we did not evaluate the 246 
associations of risk factor changes during the follow-up and the obstruction incidence. Furthermore, 247 
these associations are likely to operate in two directions as, for example, weight changes according 248 
to the lifestyle factors (daily energy intake and physical activity). Additionally, we had no data 249 
about smoked pack-years and respiratory medications used in pulmonary diseases. The follow-up 250 
time of 11 years might be, especially, in the younger age groups too short for the development of 251 
airway obstruction, and correspondingly, in older age groups too long. Additionally, the prevalence 252 
of nonresponders was biggest in the oldest age group, aged 65–100 in Health 2000 and 76 or older 253 
in Health 2011, where the physical fragility probably affected why these subjects performed not 254 
spirometry or participated in Health 2011 at all, however, this was accounted for in analyses by 255 
inverse probability weighting.  256 
 257 
Conclusions 258 
Using the similar study approach our findings on the incidence of airway obstruction are in line 259 
with the previously published figures in Europe. Our study nicely completed the previous findings 260 
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and further addressed the importance of healthy diet as an independent risk factor for the 261 
development of airway obstruction. 262 
 263 
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